GenEdit and Editas announce a worldwide, exclusive license and collaboration to enable safer and more effective delivery of CRISPR-based therapeutics.
CPI Card Group Inc. (Nasdaq: PMTS), a payment technology company providing a range of credit, debit and prepaid solutions, complementary digital solut
